Cambridge Investment Research Advisors
VHT icon

Cambridge Investment Research Advisors’s Vanguard Health Care ETF VHT Stock Holding History

Cambridge Investment Research Advisors’s Portfolio VHT Stock Details VHT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$37.2M Sell
136,583
-57,951
-30% -$16.6M 0.1% 207
2025
Q4 		$56M Buy
194,534
+17,167
+10% +$4.8M 0.15% 130
2025
Q3 		$46M Buy
177,367
+4,050
+2% +$1.02M 0.13% 146
2025
Q2 		$43M Buy
173,317
+43,488
+33% +$10.7M 0.13% 139
2025
Q1 		$34.4M Buy
129,829
+1,163
+0.9% +$310K 0.12% 170
2024
Q4 		$32.6M Sell
128,666
-63,538
-33% -$17.1M 0.11% 175
2024
Q3 		$54.2M Buy
192,204
+37,749
+24% +$10.5M 0.18% 97
2024
Q2 		$41.1M Sell
154,455
-9,171
-6% -$2.4M 0.15% 120
2024
Q1 		$44.3M Sell
163,626
-5,536
-3% -$1.45M 0.17% 110
2023
Q4 		$42.4M Sell
169,162
-32,639
-16% -$7.73M 0.18% 97
2023
Q3 		$47.4M Buy
201,801
+1,636
+0.8% +$399K 0.22% 85
2023
Q2 		$49M Buy
200,165
+7,543
+4% +$1.84M 0.22% 83
2023
Q1 		$45.9M Sell
192,622
-1,881
-1% -$453K 0.23% 86
2022
Q4 		$48.2M Buy
194,503
+3,363
+2% +$815K 0.25% 78
2022
Q3 		$42.8M Buy
191,140
+4,852
+3% +$1.16M 0.24% 74
2022
Q2 		$43.9M Buy
186,288
+3,168
+2% +$764K 0.24% 81
2022
Q1 		$46.6M Buy
183,120
+5,990
+3% +$1.48M 0.21% 85
2021
Q4 		$47.2M Buy
177,130
+10,724
+6% +$2.73M 0.21% 82
2021
Q3 		$41.1M Sell
166,406
-5,196
-3% -$1.33M 0.2% 88
2021
Q2 		$42.4M Buy
171,602
+9,600
+6% +$2.29M 0.2% 87
2021
Q1 		$37.1M Buy
162,002
+12,332
+8% +$2.83M 0.2% 86
2020
Q4 		$33.5M Sell
149,670
-4,840
-3% -$1.03M 0.2% 98
2020
Q3 		$31.5M Sell
154,510
-5,951
-4% -$1.2M 0.21% 88
2020
Q2 		$30.9M Buy
160,461
+51,202
+47% +$9.61M 0.23% 87
2020
Q1 		$18.1M Buy
109,259
+8,666
+9% +$1.58M 0.17% 125
2019
Q4 		$19.3M Buy
100,593
+858
+0.9% +$154K 0.15% 146
2019
Q3 		$16.7M Sell
99,735
-5,990
-6% -$1.03M 0.15% 144
2019
Q2 		$18.4M Sell
105,725
-6,396
-6% -$1.08M 0.17% 126
2019
Q1 		$19.3M Buy
112,121
+8,806
+9% +$1.49M 0.19% 116
2018
Q4 		$16.6M Sell
103,315
-46,989
-31% -$7.96M 0.18% 117
2018
Q3 		$27.1M Buy
150,304
+45,501
+43% +$7.82M 0.26% 76
2018
Q2 		$16.7M Buy
104,803
+36,360
+53% +$5.72M 0.18% 121
2018
Q1 		$10.5M Sell
68,443
-1,186
-2% -$189K 0.12% 167
2017
Q4 		$10.7M Sell
69,629
-28,814
-29% -$4.42M 0.13% 167
2017
Q3 		$15M Buy
98,443
+26,389
+37% +$3.94M 0.2% 99
2017
Q2 		$10.6M Buy
72,054
+1,395
+2% +$197K 0.16% 122
2017
Q1 		$9.74M Sell
70,659
-446
-0.6% -$60.1K 0.17% 116
2016
Q4 		$9.01M Buy
71,105
+1,199
+2% +$153K 0.17% 118
2016
Q3 		$9.29M Buy
69,906
+1,642
+2% +$221K 0.17% 110
2016
Q2 		$8.91M Buy
68,264
+2,425
+4% +$311K 0.19% 107
2016
Q1 		$8.12M Sell
65,839
-11,102
-14% -$1.35M 0.18% 112
2015
Q4 		$10.2M Sell
76,941
-3,147
-4% -$410K 0.24% 90
2015
Q3 		$9.82M Sell
80,088
-17,748
-18% -$2.43M 0.28% 72
2015
Q2 		$13.7M Buy
97,836
+25,434
+35% +$3.51M 0.38% 56
2015
Q1 		$9.81M Buy
72,402
+10,494
+17% +$1.38M 0.28% 78
2014
Q4 		$7.78M Buy
61,908
+15,622
+34% +$1.92M 0.24% 89
2014
Q3 		$5.42M Buy
46,286
+8,882
+24% +$1.02M 0.16% 133
2014
Q2 		$4.17M Sell
37,404
-27,041
-42% -$2.89M 0.15% 138
2014
Q1 		$6.89M Buy
64,445
+8,697
+16% +$920K 0.26% 82
2013
Q4 		$5.64M Buy
55,748
+6,537
+13% +$641K 0.23% 94
2013
Q3 		$4.58M Buy
49,211
+4,983
+11% +$457K 0.2% 113
2013
Q2 		$3.82M Buy
+44,228
New +$3.82M 0.19% 110

Other funds holding VHT

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PCH
PGIM Custom Harvest Newark, New Jersey $6.4B AUM 18.53% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Cambridge Investment Research Advisors's VHT Position: Q1 2026 in Review

Cambridge Investment Research Advisors reduced its Vanguard Health Care ETF (VHT) stake by 30% in Q1 2026, selling an estimated $16.6M and leaving 136,583 shares worth $37.2M. The position accounts for 0.1% of the portfolio, ranked #207.

Cambridge Investment Research Advisors first reported a position in VHT in Q2 2013 and has held it in 52 quarters since. The position peaked at $56M in Q4 2025. 1,085 funds tracked by Wall St. Rank hold VHT as of Q1 2026.

  • Cambridge Investment Research Advisors held 136,583 shares of Vanguard Health Care ETF worth $37.2M as of Q1 2026.
  • Cambridge Investment Research Advisors sold 57,951 Vanguard Health Care ETF shares in Q1 2026, an estimated $16.6M.
  • Vanguard Health Care ETF made up 0.1% of Cambridge Investment Research Advisors's portfolio in Q1 2026, its #207 holding.
  • Cambridge Investment Research Advisors first reported a position in Vanguard Health Care ETF in Q2 2013 and has held it in 52 quarters since.
  • Cambridge Investment Research Advisors's Vanguard Health Care ETF position peaked at $56M in Q4 2025.
  • 1,085 funds tracked by Wall St. Rank held Vanguard Health Care ETF as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.